Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Johnson & Johnson raised its 2024 profit and sales forecasts following strong sales of its oncology drugs. The healthcare ...

Johnson & Johnson raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology drugs and ...

York-based Abingdon Health has signed a lease to open a commercial office and laboratory in Wisconsin in the US to support ...

Abingdon Health, a medical device contract development and manufacturing organisation (CDMO), has signed a lease to open a ...

Laura Henry, head of finance and talent development, Cirdan, Mark Sterritt British Business Bank director, Bernard McGuire MD ...

As Chinese equities have recently experienced a decline amid waning optimism about Beijing's stimulus measures, investors are ...

The MHRA recently published an update on its plans for MedTech regulatory change. The update confirmed that the new framework will be ...

Johnson & Johnson, along with its orthopedic company, DePuy Synthes, saw multiple product advancements and growth in the third quarter.

For medical startups, intellectual property represents a crucial asset. Yet the patent landscape remains complex, rang ...

Baxter International began shipments of intravenous products to the United States from two international facilities last week, it said on Monday, as it seeks to bring a hurricane-hit plant in North ...

Johnson & Johnson (JNJ) is set to announce Q3 earnings on October 15th. Analysts expect profit of $2.21 on revenue of $22.17B ...